1
Marchi Egidio, Rotini Leone Gabriele, Desai Subhash, Grilli Massimo: Alfa Wassermann S p A, Bucknam and Archer, October 31, 2000: US06140355 (68 worldwide citation)

Vaginal pharmaceutical compositions administrable through the topical route, particularly in the form of foams and creams containing a therapeutically effective amount of rifaximin (Common International Denomination) are useful in the treatment of vaginal infections, particularly bacterial vaginosis ...


2
Marchi Egidio, Rotini L Gabriele, Desai Subhash, Grillli Massimo: Alfa Wassermann S p A, Bucknam and Archer, May 24, 1994: US05314904 (67 worldwide citation)

Vaginal pharmaceutical compositions administrable through the topical route, particularly in the form of vaginal foams and creams containing a therapeutically effective amount of rifaximin (Common International Denomination) are useful in the treatment of vaginal infections, particularly bacterial v ...


3
Rotini Leone Gabriele, Marchi Egidio: New pharmaceutical formulations with programmed release containing antiphlogistics.. Alfa Farmaceutici, February 3, 1988: EP0255002-A1 (28 worldwide citation)

New galenic formulations with programmed release, to be administered by oral route, containing as the active ingredient a compound endowed with antiphlogistic, analgesic and antipyretic activity like, for instance, an arylacetic or an arylpropionic acid and the pharmaceutically acceptable salts ther ...


4
Marchi Egidio, Tamagnone Gianfranco, Rotini L Gabriele: Gastroresistant pharmaceutical formulations for oral administration containing salts of bile acids. Alfa Wassermann S p A, Bucknam and Archer, April 12, 1994: US05302398 (26 worldwide citation)

Pharmaceutical formulations for oral administration coated by an enterosoluble gastroresistant film, preferably selected from gastroresistant granulates, gastroresistant tablets, gastroresistant hard gelatine capsules containing powders or granulates or two or more tablets or oily suspensions, gastr ...


5
Marchi Egidio, Tamagnone Gianfranco: Controlled release gastroresistant pharmaceutical formulations for oral administration containing bile acids and their salts. Alfa Wassermann S p A, Bucknam and Archer, April 5, 1994: US05300300 (26 worldwide citation)

Controlled release pharmaceutical formulations for oral administration coated by an enterosoluble gastroresistant film, preferably selected from gastroresistant granulates, gastroresistant tablets, gastroresistant hard gelatine capsules containing powders or granulates or two or more tablets or oily ...


6
Cristofori Manlio, Marchi Egidio, Rotini Leone Gabrielle: Pharmaceutical compositions containing orally absorbable glycosaminoglycans.. Alfa Wassermann, August 5, 1992: EP0497162-A1 (24 worldwide citation)

Pharmaceutical compositions for oral use, preferably selected from capsules, tablets or sugar coated tablets, coated by an enterosoluble gastroresistant film, containing a lyophilisate made by therapeutically effective amounts of a glycosaminoglycan, a thickening substance and surfactants, and proce ...


7
Marchi Egidio, Tamagnone Gianfranco: Use of glycosaminoglycans in the treatment of diabetic nephropathy and diabetic neuropathy. ALFA Wassermann S p A, Bucknam and Archer, August 17, 1993: US05236910 (13 worldwide citation)

The object of the present invention is the manufacture of a medicine for the use of glycosaminoglycans in the prevention and treatment of some pathologies caused by diabetes, like diabetic nephropathy and diabetic neuropathy.


8
Rotini Leone Gabriele, Marchi Egidio: New galenic formulations with programmed release.. Alfa Wassermann, July 26, 1989: EP0324981-A1 (12 worldwide citation)

New galenic formulations with programmed release, to be administered by oral route, containing as the active ingredient a drug selected from the non steroidal antiinflammatory, bronchodilator, vasodilator, cardiovascular and muscle relaxant drugs. In these new formulations, a portion of the active i ...


9
Marchi Egidio, Tamagnone Gianfranco: Use of glycosaminoglycans in the treatment of diabetic nephropathy and diabetic neuropathy.. Alfa Wassermann, November 19, 1992: EP0513513-A1 (12 worldwide citation)

The object of the present invention is the manufacture of a medicine for the use of glycosaminoglycans in the prevention and treatment of some pathologies caused by diabetes, like diabetic nephropathy and diabetic neuropathy. The effectiveness of glycosaminoglycans in the prevention and treatment of ...


10
Marchi Egidio, Tamagnone Gianfranco, Rotini Leone Gabriele: Gastroresistant pharmaceutical formulations for oral administration containing bile acids.. Alfa Wassermann, October 21, 1992: EP0509335-A1 (11 worldwide citation)

Pharmaceutical formulations for oral administration coated by an enterosoluble gastroresistant film, preferably selected from gastroresistant granulates, gastroresistant tablets, gastroresistant hard gelatine capsules containing powders or granulates or two or more tablets or oily suspensions, gastr ...